PubRank

Brady S Moffett

Author PubWeight™ 19.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin J Am Soc Nephrol 2008 2.18
2 Agreement among measurements and estimations of glomerular filtration in children with cancer. Pediatr Blood Cancer 2014 1.98
3 Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant 2010 1.95
4 Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure. J Card Fail 2006 1.08
5 Hemodynamic effects of rescue protocol hydrocortisone in neonates with low cardiac output syndrome after cardiac surgery. Pediatr Crit Care Med 2005 1.02
6 Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 2011 0.89
7 Sodium-nitroprusside-induced cyanide toxicity in pediatric patients. Expert Opin Drug Saf 2009 0.88
8 Altered gentamicin serum concentrations in obese pediatric patients. Pediatr Infect Dis J 2011 0.86
9 Perioperative atrial tachycardia is associated with increased mortality in infants undergoing cardiac surgery. J Thorac Cardiovasc Surg 2012 0.85
10 High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol 2011 0.85
11 Impact of dexmedetomidine on early extubation in pediatric cardiac surgical patients. Intensive Care Med 2011 0.83
12 Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol 2010 0.82
13 Once-daily gentamicin dosing in pediatric patients without cystic fibrosis. Pharmacotherapy 2010 0.80
14 Vancomycin nephrotoxicity may be overstated. J Pediatr 2011 0.80
15 Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia. Pediatr Cardiol 2008 0.80
16 Drug shortages: implications on pediatric anesthesia practice and management resources. J Clin Anesth 2012 0.80
17 Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease. Pediatr Cardiol 2014 0.78
18 Safety and efficacy of nesiritide in pediatric heart failure. J Card Fail 2007 0.77
19 Infectious complications and outcomes in children supported with left ventricular assist devices. J Heart Lung Transplant 2013 0.77
20 An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent. J Heart Lung Transplant 2006 0.75
21 Race contributes to beta-blocker efficacy in pediatric patients with arrhythmias. Pediatr Cardiol 2013 0.75
22 Impact of Body Habitus on Phenytoin Levels Following Fosphenytoin Loading Dose in Pediatric Patients. Ther Drug Monit 2015 0.75
23 Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients. Pediatr Cardiol 2013 0.75
24 Warfarin anticoagulation after congenital heart surgery at a large children's hospital. Pediatr Cardiol 2012 0.75
25 Captopril induced reversible acute renal failure in a premature neonate with double outlet right ventricle and congestive heart failure. World J Pediatr 2010 0.75
26 Prescribing errors in adult congenital heart disease patients admitted to a pediatric cardiovascular intensive care unit. Congenit Heart Dis 2013 0.75
27 Response to intravenous potassium chloride supplementation in pediatric cardiac intensive care patients. Pediatr Cardiol 2012 0.75
28 Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin. J Pediatr 2012 0.75
29 Evaluation of weight-based dosing of unfractionated heparin in obese children. J Pediatr 2013 0.75
30 The authors reply. Pediatr Crit Care Med 2019 0.75
31 Incidence of adverse events requiring intervention after initiation of oral beta-blocker in pediatric cardiac intensive care patients. Pediatr Cardiol 2014 0.75
32 Use of 4-Factor Prothrombin Concentrate (Kcentra) in Hospitalized Pediatric Patients. Ann Pharmacother 2015 0.75